• Akinori Miyakoshi, Eiji Nakatani, Hideaki Kaneda, Philip Hawke, Hatoko Sasaki, Tetsumei Urano, and Yoshiki Miyachi.
• Shizuoka Graduate University of Public Health, Shizuoka , Japan.
• Neurosurgery. 2023 Nov 1; 93 (5): 116011671160-1167.

BackgroundAlthough tranexamic acid (TXA) has occasionally been used to prevent postoperative recurrence of chronic subdural hematoma (CSDH) after burr hole craniotomy (BC), robust evidence of its efficacy has been lacking.ObjectiveTo assess the efficacy and safety of postoperative oral administration of TXA after BC for CSDH among the elderly.MethodsThis retrospective, propensity score-matched cohort study was carried out with a large Japanese local population-based longitudinal cohort in the Shizuoka Kokuho Database between April 2012 and September 2020. Patients included were age 60 years or older and had undergone BC for CSDH but were not undergoing dialysis. Covariates were collected from records of the preceding 12 months from the month of first BC, and patients were followed up for 6 months after surgery. The primary outcome was repeat surgery, and the secondary outcome was death or the onset of thrombosis. Data on postoperative TXA administration were collected and compared with controls using propensity score matching.ResultsOf the 8544 patients who underwent BC for CSDH, 6647 were included, with 473 placed in the TXA group and 6174 placed in the control group. After 1:1 matching, repeated BC was found to have been performed in 30 of 465 patients (6.5%) in the TXA group and in 78 of 465 patients (16.8%) in the control group (relative risk, 0.38; 95% CI, 0.26-0.56). No significant difference was observed for death or the onset of thrombosis.ConclusionOral administration of TXA reduced the occurrence of repeat surgery after BC for CSDH.Copyright © Congress of Neurological Surgeons 2023. All rights reserved.

27 keywords...

hide…